A Whole-grain Diet Reduces Peripheral Insulin Resistance and Improves Glucose Kinetics in Obese Adults: A Randomized-controlled Trial
Overview
Authors
Affiliations
Background: Whole-grain intake is associated with lower risk of type 2 diabetes but the mechanisms are unclear.
Purpose: We tested the hypothesis that a WG diet reduces insulin resistance and improves glucose use in individuals at risk for type 2 diabetes compared with an isocaloric-matched refined-grain diet.
Methods: A double-blind, randomized, controlled, crossover trial of 14 moderately obese adults (Age, 38 ± 2 y; BMI, 34.0 ± 1.1 kg/m). Insulin resistance and glucose metabolism was assessed using an oral glucose tolerance test combined with isotopic tracers of [6,6-H]-glucose and [U-C]-glucose, and indirect calorimetry. Peripheral and hepatic insulin resistance was assessed as 1/(rate of disposal/insulin), and endogenous glucose rates of appearance (R) iAUC × insulin iAUC, respectively. Both diets met ADA nutritional guidelines and contained either whole-grain (50 g per 1000 kcal) or equivalent refined-grain. All food was provided for 8 wk. with an 8-10 wk. washout period between diets.
Results: Post-prandial glucose tolerance, peripheral insulin sensitivity, and metabolic flexibility (insulin-stimulated - fasting carbohydrate oxidation) improvements were greater after whole-grain compared to the refined-grain diet (P < 0.05). Compared to baseline, body fat (~2 kg) and hepatic R insulin resistance was reduced by both diets, while fasting glucose and exogenous glucose-meal were unchanged after both interventions. Changes in peripheral insulin resistance and metabolic flexibility correlated with improved glucose tolerance (P < 0.05).
Conclusion: Whole-grains reduced diabetes risk and the mechanisms appear to work through reduced post-prandial blood glucose and peripheral insulin resistance that were statistically linked to enhanced metabolic flexibility.
The Effect of Anxiety and Nutritional Habits on the Body Distortion of Athletes.
Ramirez-Goerke M, Tornero-Aguilera J, Martin-Rodriguez A, Clemente-Suarez V Nutrients. 2025; 17(4).
PMID: 40005010 PMC: 11858329. DOI: 10.3390/nu17040682.
Alzubi A, Glowacki H, Burns J, Van K, Martin J, Monk J Nutrients. 2025; 17(3).
PMID: 39940429 PMC: 11820615. DOI: 10.3390/nu17030571.
Xu M, Wei H, Lv D, Wei Y, Liu Z, Zhang Y Front Nutr. 2025; 11:1494383.
PMID: 39872139 PMC: 11769828. DOI: 10.3389/fnut.2024.1494383.
Jin Y, Wan K, Liu C, Cheng W, Wang R Front Endocrinol (Lausanne). 2024; 15:1401342.
PMID: 39149117 PMC: 11324446. DOI: 10.3389/fendo.2024.1401342.
Song L, Li Y, Xu M Nutrients. 2024; 16(12).
PMID: 38931156 PMC: 11206901. DOI: 10.3390/nu16121801.